Learn More
Apexbio Technology LLC Bortezomib (PS-341), 500mg. Cas: 179324-69-7 MFCD: MFCD09056737. Proteasome Inhibitor

Supplier: Apexbio Technology LLC A2614500

Bortezomib (originally codenamed PS-341) is the first therapeutic proteasome inhibitor to the tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. Other sizes are available. Please inqury us for quote.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.